{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:20:16Z","timestamp":1790162416137,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11916-019-0777-x","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T07:04:02Z","timestamp":1565075042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Tramadol Prescription over a 4-Year Period in the USA"],"prefix":"10.1007","volume":"23","author":[{"given":"Luisa M.","family":"Bigal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"issue":"1","key":"777_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1.","volume":"65","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou RCDC. Guideline for prescribing opioids for chronic pain - United States. 2016 MMWR Recomm Rep. 2016;65(1):1\u201349. \n                    https:\/\/doi.org\/10.15585\/mmwr.rr6501e1.","journal-title":"2016 MMWR Recomm Rep"},{"issue":"3","key":"777_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1155\/2011\/434298","volume":"16","author":"M Kahan","year":"2011","unstructured":"Kahan M, Mailis-Gagnon A, Tunks E. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain: implications for pain physicians. Pain Res Manag. 2011;16(3):157\u20138.","journal-title":"Pain Res Manag"},{"issue":"5","key":"777_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/j.pain.0000000000000475","volume":"157","author":"CB Groenewald","year":"2016","unstructured":"Groenewald CB, Rabbitts JA, Gebert JT, Palermo TM. Trends in opioid prescriptions among children and adolescents in the United States: a nationally representative study from 1996 to 2012. Pain. 2016;157(5):1021\u20137. \n                    https:\/\/doi.org\/10.1097\/j.pain.0000000000000475\n                    \n                  .","journal-title":"Pain."},{"issue":"3","key":"777_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143.","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJMsa1406143.","journal-title":"N Engl J Med"},{"issue":"10","key":"777_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/MLR.0b013e3182a95d86","volume":"51","author":"M Daubresse","year":"2013","unstructured":"Daubresse M, Chang HY, Yu Y, Viswanathan S, Shah ND, Stafford RS, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51(10):870\u20138. \n                    https:\/\/doi.org\/10.1097\/MLR.0b013e3182a95d86\n                    \n                  .","journal-title":"Med Care"},{"issue":"12","key":"777_CR6","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/pds.1833","volume":"18","author":"D Boudreau","year":"2009","unstructured":"Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1166\u201375. \n                    https:\/\/doi.org\/10.1002\/pds.1833\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"21","key":"777_CR7","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMp1011512","volume":"363","author":"S Okie","year":"2010","unstructured":"Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med. 2010;363(21):1981\u20135. \n                    https:\/\/doi.org\/10.1056\/NEJMp1011512\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"5","key":"777_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40258-018-0402-x","volume":"16","author":"Marcia Reinhart","year":"2018","unstructured":"Reinhart M, Scarpati LM, Kirson NY, et al. The economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017. Appl Health Econ Health Policy. 2018. \n                    https:\/\/doi.org\/10.1007\/s40258-018-0402-x\n                    \n                  .","journal-title":"Applied Health Economics and Health Policy"},{"issue":"3","key":"777_CR9","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2105\/AJPH.2015.302982","volume":"106","author":"D Herzberg","year":"2016","unstructured":"Herzberg D, Guarino H, Mateu-Gelabert P, Bennett AS. Recurring epidemics of pharmaceutical drug abuse in America: time for an all-drug strategy. Am J Public Health. 2016;106(3):408\u201310. \n                    https:\/\/doi.org\/10.2105\/AJPH.2015.302982\n                    \n                  .","journal-title":"Am J Public Health"},{"issue":"4","key":"777_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5055\/jom.2014.0214.","volume":"10","author":"SD Passik","year":"2014","unstructured":"Passik SD, Webster L. Opioid analgesics: does potency matter? J Opioid Manag. 2014;10(4):263\u201375. \n                    https:\/\/doi.org\/10.5055\/jom.2014.0214.","journal-title":"J Opioid Manag"},{"key":"777_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/JPR.S67817","volume":"7","author":"AS Chandanwale","year":"2014","unstructured":"Chandanwale AS, Sundar S, Latchoumibady K, et al. Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a phase III, 5-day open-label study. J Pain Res. 2014;7:455\u201363. \n                    https:\/\/doi.org\/10.2147\/JPR.S67817\n                    \n                  .","journal-title":"J Pain Res"},{"issue":"3","key":"777_CR12","first-page":"543","volume":"34","author":"MS Cepeda","year":"2007","unstructured":"Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007;34(3):543\u201355.","journal-title":"J Rheumatol"},{"issue":"10","key":"777_CR13","first-page":"1964","volume":"72","author":"J Sonis","year":"2005","unstructured":"Sonis J. Tramadol for acute pain: a review of the evidence. Am Fam Physician. 2005;72(10):1964 author reply 1964, 1966.","journal-title":"Am Fam Physician"},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1874325001509010120","volume":"9","author":"T Imamura","year":"2015","unstructured":"Imamura T. Significant efficacy of tramadol\/acetaminophen in elderly patients with chronic low back pain uncontrolled by NSAIDs: an observational study. Open Orthop J. 2015;9:120\u20135. \n                    https:\/\/doi.org\/10.2174\/1874325001509010120\n                    \n                  .","journal-title":"Open Orthop J"},{"issue":"2","key":"777_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1056-8727(00)00060-X","volume":"14","author":"Y Harati","year":"2000","unstructured":"Harati Y, Gooch C, Swenson M, Edelman SV, Greene D, Raskin P, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complicat. 2000;14(2):65\u201370.","journal-title":"J Diabetes Complicat"},{"key":"777_CR16","unstructured":"Administration US-DE. Drug scheduling [cited 2018 08\/07\/2018]. Available from: \n                    https:\/\/www.dea.gov\/druginfo\/ds.shtml"},{"issue":"1","key":"777_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15563650.2013.872791.","volume":"52","author":"SA Handley","year":"2014","unstructured":"Handley SA, Flanagan RJ. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000 - 2011. Clin Toxicol (Phila). 2014 Jan;52(1):1\u201312. \n                    https:\/\/doi.org\/10.3109\/15563650.2013.872791.","journal-title":"Clin Toxicol (Phila)"},{"key":"777_CR18","volume-title":"Report of the international narcotics control board for 2012","author":"Board INC","year":"2013","unstructured":"Board INC. Report of the international narcotics control board for 2012. New York: United Nations; 2013. [cited 2018 08\/07\/2018]. Available from: \n                    http:\/\/incb.org\/documents\/Publications\/AnnualReports\/AR2012\/AR_2012_E.pdf\n                    \n                  ."},{"key":"777_CR19","unstructured":"Analytics TH. Market scan studies - abbreviated bibliography 2018 [cited 2018 09\/14\/2018]. Available from: \n                    http:\/\/truvenhealth.com\/Portals\/0\/Assets\/2017_Truven_Health_MarketScan_Bibliography.pdf\n                    \n                  ."},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eplepsyres.2018.07.012.","volume":"146","author":"X DeGrauw","year":"2018","unstructured":"DeGrauw X, Thurman D, Xu L, Kancherla V, DeGrauw T. Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: an analysis of insurance claims data, 2004-2014. Epilepsy Res. 2018 Jul 23;146:41\u20139. \n                    https:\/\/doi.org\/10.1016\/j.eplepsyres.2018.07.012.","journal-title":"Epilepsy Res"},{"issue":"1","key":"777_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/pds.4572","volume":"28","author":"Jessica C. Young","year":"2018","unstructured":"Young JC, Lund JL, Dasgupta N, et al. Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids. Pharmacoepidemiol Drug Saf. 2018. \n                    https:\/\/doi.org\/10.1002\/pds.4572\n                    \n                  .","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"1","key":"777_CR22","first-page":"52","volume":"5","author":"RA Puenpatom","year":"2012","unstructured":"Puenpatom RA, Szeinbach SL, Ma L, et al. Daily average consumption of 2 long-acting opioids: an interrupted time series analysis. Am Health Drug Benefits. 2012;5(1):52\u201360.","journal-title":"Am Health Drug Benefits"},{"key":"777_CR23","unstructured":"Analytics TH. The Truven Health MarketScan Databases for health services researchers 2018. Available from: \n                    https:\/\/truvenhealth.com\/portals\/0\/assets\/2017_MarketScan_Databases_Health_Services_Researchers.pdf\n                    \n                  ."},{"issue":"15","key":"777_CR24","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464.","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou RCDC. Guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624\u201345. \n                    https:\/\/doi.org\/10.1001\/jama.2016.1464.","journal-title":"JAMA"},{"issue":"3","key":"777_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","volume":"49","author":"B Levy","year":"2015","unstructured":"Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med. 2015;49(3):409\u201313. \n                    https:\/\/doi.org\/10.1016\/j.amepre.2015.02.020\n                    \n                  .","journal-title":"Am J Prev Med"},{"issue":"3","key":"777_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11916-018-0670-z.","volume":"22","author":"N Vadivelu","year":"2018","unstructured":"Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The opioid crisis: a comprehensive overview. Curr Pain Headache Rep. 2018 Feb 23;22(3):16. \n                    https:\/\/doi.org\/10.1007\/s11916-018-0670-z.","journal-title":"Curr Pain Headache Rep"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/JPR.S129553","volume":"10","author":"EJ Pezalla","year":"2017","unstructured":"Pezalla EJ, Rosen D, Erensen JG, Haddox D, Mayne TJ. Secular trends in opioid prescribing in the USA. J Pain Res. 2017;10:383\u20137. \n                    https:\/\/doi.org\/10.2147\/JPR.S129553\n                    \n                  .","journal-title":"J Pain Res"},{"issue":"34","key":"777_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(34):897\u2013903. \n                    https:\/\/doi.org\/10.15585\/mmwr.mm6634a2\n                    \n                  .","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"777_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jhm.2350","volume":"10","author":"Y Liang","year":"2015","unstructured":"Liang Y, Turner BJ. National cohort study of opioid analgesic dose and risk of future hospitalization. J Hosp Med. 2015;10(7):425\u201331. \n                    https:\/\/doi.org\/10.1002\/jhm.2350\n                    \n                  .","journal-title":"J Hosp Med"},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11524-018-0250-x.","volume":"96","author":"C Rowe","year":"2018","unstructured":"Rowe C, Wheeler E, Stephen Jones T, Yeh C, Coffin PO. Community-based response to fentanyl overdose outbreak, San Francisco, 2015. J Urban Health. 2018;96:6\u201311. \n                    https:\/\/doi.org\/10.1007\/s11524-018-0250-x.","journal-title":"J Urban Health"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addbeh.2018.03.010","volume":"86","author":"P Phalen","year":"2018","unstructured":"Phalen P, Ray B, Watson DP, Huynh P, Greene MS. Fentanyl related overdose in Indianapolis: estimating trends using multilevel Bayesian models. Addict Behav. 2018;86:4\u201310. \n                    https:\/\/doi.org\/10.1016\/j.addbeh.2018.03.010\n                    \n                  .","journal-title":"Addict Behav"},{"issue":"3","key":"777_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/pm\/pnx015","volume":"19","author":"MC Mercado","year":"2018","unstructured":"Mercado MC, Sumner SA, Spelke MB, Bohm MK, Sugerman DE, Stanley C. Increase in drug overdose deaths involving fentanyl-Rhode Island, January 2012-March 2014. Pain Med. 2018;19(3):511\u201323. \n                    https:\/\/doi.org\/10.1093\/pm\/pnx015\n                    \n                  .","journal-title":"Pain Med"},{"issue":"2","key":"777_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","volume":"108","author":"N Dasgupta","year":"2018","unstructured":"Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182\u20136. \n                    https:\/\/doi.org\/10.2105\/AJPH.2017.304187\n                    \n                  .","journal-title":"Am J Public Health"},{"issue":"6","key":"777_CR34","doi-asserted-by":"publisher","first-page":"e020097","DOI":"10.1136\/bmjopen-2017-020097","volume":"8","author":"T Minegishi","year":"2018","unstructured":"Minegishi T, Garrido MM, Pizer SD, et al. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design. BMJ Open. 2018;8(6):e020097. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2017-020097\n                    \n                  .","journal-title":"BMJ Open"},{"issue":"1","key":"777_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13011-017-0130-5","volume":"12","author":"KA Morin","year":"2017","unstructured":"Morin KA, Eibl JK, Franklyn AM, Marsh DC. The opioid crisis: past, present and future policy climate in Ontario, Canada. Subst Abuse Treat Prev Policy. 2017;12(1):45. \n                    https:\/\/doi.org\/10.1186\/s13011-017-0130-5\n                    \n                  .","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"14","key":"777_CR36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/jama.2018.1353","volume":"319","author":"R Voelker","year":"2018","unstructured":"Voelker R. A day in the life: facing the opioid epidemic in Huntington, West Virginia. JAMA. 2018;319(14):1423\u20134. \n                    https:\/\/doi.org\/10.1001\/jama.2018.1353\n                    \n                  .","journal-title":"JAMA."},{"issue":"1","key":"777_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3844\/amjsp.2015.9.13","volume":"6","author":"A Beheshti","year":"2015","unstructured":"Beheshti A, Lucas L, Dunz T, et al. An evaluation of naloxone use for opioid overdoses in West Virginia: a literature review. Am Med J. 2015;6(1):9\u201313. \n                    https:\/\/doi.org\/10.3844\/amjsp.2015.9.13\n                    \n                  .","journal-title":"Am Med J"},{"issue":"16","key":"777_CR38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMc1501822.","volume":"372","author":"RB Bolash","year":"2015","unstructured":"Bolash RB. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(16):1573\u20134. \n                    https:\/\/doi.org\/10.1056\/NEJMc1501822.","journal-title":"N Engl J Med"},{"issue":"5","key":"777_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pds.3989.","volume":"25","author":"K Smolina","year":"2016","unstructured":"Smolina K, Gladstone E, Morgan SG. Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013. Pharmacoepidemiol Drug Saf. 2016 May;25(5):553\u20139. \n                    https:\/\/doi.org\/10.1002\/pds.3989.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"777_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/pds.4376","volume":"27","author":"MA Raji","year":"2018","unstructured":"Raji MA, Kuo YF, Adhikari D, Baillargeon J, Goodwin JS. Decline in opioid prescribing after federal rescheduling of hydrocodone products. Pharmacoepidemiol Drug Saf. 2018;27(5):513\u20139. \n                    https:\/\/doi.org\/10.1002\/pds.4376\n                    \n                  .","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"777_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamainternmed.2015.7799.","volume":"176","author":"CM Jones","year":"2016","unstructured":"Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration\u2019s rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176(3):399\u2013402. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2015.7799.","journal-title":"JAMA Intern Med"},{"issue":"12","key":"777_CR42","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.ajem.2016.09.002.","volume":"34","author":"EC Oehler","year":"2016","unstructured":"Oehler EC, Day RL, Robinson DB, Brown LH. Has the rescheduling of hydrocodone changed ED prescribing practices? Am J Emerg Med. 2016;34(12):2388\u201391. \n                    https:\/\/doi.org\/10.1016\/j.ajem.2016.09.002.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"777_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5055\/jom.2016.0323.","volume":"12","author":"S Schultz","year":"2016","unstructured":"Schultz S, Chamberlain C, Vulcan M, et al. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. J Opioid Manag. 2016;12(2):119\u201322. \n                    https:\/\/doi.org\/10.5055\/jom.2016.0323.","journal-title":"J Opioid Manag"},{"key":"777_CR44","unstructured":"Health MDo. Patterns of opioid prescribing in Minnesota: 2012 and 2015 [cited 2018 08\/17\/2018]. Available from: \n                    http:\/\/www.health.state.mn.us\/divs\/hpsc\/hep\/publications\/opioidbrief20185.pdf\n                    \n                  ."},{"key":"777_CR45","unstructured":"Control CfD. Prescription drug time and dosage limit Laws. 2017 [cited 2018 11\/04\/2018]. Available from: \n                    https:\/\/www.cdc.gov\/phlp\/docs\/menu_prescriptionlimits.pdf"},{"issue":"11","key":"777_CR46","doi-asserted-by":"publisher","first-page":"1382.e1-1382.e6","DOI":"10.1016\/j.amjmed.2018.04.025","volume":"131","author":"Sameer Hassamal","year":"2018","unstructured":"Hassamal S, Miotto K, Dale W, et al. Tramadol: understanding the risk of serotonin syndrome and seizures. Am J Med. 2018. \n                    https:\/\/doi.org\/10.1016\/j.amjmed.2018.04.025\n                    \n                  .","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"777_CR47","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/0259-1162.177181","volume":"10","author":"SG Beyaz","year":"2016","unstructured":"Beyaz SG, Sonbahar T, Bayar F, Erdem AF. Seizures associated with low-dose tramadol for chronic pain treatment. Anesth Essays Res. 2016;10(2):376\u20138. \n                    https:\/\/doi.org\/10.4103\/0259-1162.177181\n                    \n                  .","journal-title":"Anesth Essays Res"},{"issue":"14","key":"777_CR48","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","volume":"66","author":"NJ Somerville","year":"2017","unstructured":"Somerville NJ, O\u2019Donnell J, Gladden RM, et al. Characteristics of fentanyl overdose - Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382\u20136. \n                    https:\/\/doi.org\/10.15585\/mmwr.mm6614a2\n                    \n                  .","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"777_CR49","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/jat\/bky026.","volume":"42","author":"NB Tiscione","year":"2018","unstructured":"Tiscione NB, Alford I. Carfentanil in impaired driving cases and the importance of drug seizure data. J Anal Toxicol. 2018;42(7):476\u201384. \n                    https:\/\/doi.org\/10.1093\/jat\/bky026.","journal-title":"J Anal Toxicol"},{"issue":"5","key":"777_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40258-018-0402-x","volume":"16","author":"M Reinhart","year":"2018","unstructured":"Reinhart M, Scarpati LM, Kirson NY, Patton C, Shak N, Erensen JG. The economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017. Appl Health Econ Health Policy. 2018;16(5):609\u201332. \n                    https:\/\/doi.org\/10.1007\/s40258-018-0402-x\n                    \n                  .","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"777_CR51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014.","volume":"51","author":"CS Hwang","year":"2016","unstructured":"Hwang CS, Kang EM, Kornegay CJ, Staffa JA, Jones CM, McAninch JK. Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014. Am J Prev Med. 2016;51(2):151\u201360. \n                    https:\/\/doi.org\/10.1016\/j.amepre.2016.02.014.","journal-title":"Am J Prev Med"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0777-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-019-0777-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-019-0777-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T23:11:24Z","timestamp":1596582684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-019-0777-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":51,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s11916-019-0777-x","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"6 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Luisa M. Bigal conducted this study as part of a paid internship at Teva Pharmaceuticals. Kristen Bibeau is a full-time employee at Incyte Corporation and was a full-time employee at Teva at the time of data collection. Stephanie Dunbar is a full-time employee at Teva.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"76"}}